OBJECTIVE To explore the clinical efficacy of adenoidectomy in treating pediatric secretory otitis media,sinusitis and snoring. METHODS A retrospective study was conducted to analyze the clinical features,therapeutic methods and prognosis of 68 children in hospital who underwent adenoidectomy to treat secretory otitis media,sinusitis or snoring. RESULTS The conditions of the 68 children were marked improved after the removal of hypertrophic adenoids. The total clinical effectiveness rate was 100 % and the cure rate was 86.8 %. CONCLUSION Hypertrophic adenoids is a fundamental cause of pediatric secretory otitis media,sinusitis and snoring. The removal of hypertrophic adenoids is a safe and effective method for treating pediatric secretory otitis media,sinusitis and snoring.

Objective To investigate the application of PKH26 fluorescent labeling on nucleus pulposus cells isolat-ed from bovine coccyx disc, and to provide nucleus pulposus tissue engineering with traceable nucleus pulposus cells by PKH26 fluorescence labelling. Methods Nucleus pulposus primary cells were isolated from the nucleus pulposus tissue de-tached from bovine coccyx disc by enzymatic digestion, and observed under the inverted microscope. Safranin O, toluidine blue and type Ⅱ collagen immunocytochemistry methods used to stain for passage one generation cells. Nucleus pulposus cells were labeled with PKH26 fluorescence in accordance with the instructions. The cell activity, fluorescence intensity at d0, d14 and d28 of culture, characteristics of proliferation and the expression of gene in labeled cells were assessed. Re-sults Isolated nucleus pulposus cells amounted to (1.56 ± 0.35) × 106/g. Under the inverted microscope, primary cells ad-hered at the 4 th day of culture, grew in groups, and covered the bottom of culture flask at the 13 th day. Both primary cells and the P1 generation cells were chondrocyte-like morphology. The staining of safranin O, toluidine blue and typeⅡcolla-gen immunocytochemistry for P1 generation of nucleus pulposus cells showed positive results. The cell activity before and af-ter PKH26 labeling showed more than 95%, and the fluorescence intensity at d0, d14 and d28 performed a decreasing trend, but still showed detect strong fluorescence at d28. There were no significant differences in proliferation and the expression of gene (collagen typeⅠandⅡ, aggrecan) before and after cell labeling (P>0.05). Conclusion As the seed cells of tissue en-gineering, nucleus pulposus cells isolated from bovine coccyx can reach a satisfactory number and maintain cartilage-like phenotype, and no changes shown in the biological characteristics after labeling. PKH26 labeled nucleus pulposus cells are suitable for the traceable cells in vivo study.

Objectives:To explore the curative effect of posterior lumbar interbody fusion under Delta large channel endoscope(Endo-PLIF)on degenerative lumbar diseases.Methods:A retrospective analysis was per-formed on the case data of 80 patients with degenerative lumbar diseases treated in the hospital between September 2021 and September 2022.The patients were divided into observation group(38 cases,17 males and 21 females,aged 61.0±4.9 years)and control group(42 cases,20 males and 22 females,aged 60.5±5.4 years).The patients in the observation group were treated with Endo-PLIF,while those in the control group were treated with open posterior lumbar interbody fusion.The intraoperative blood loss,postoperative drainage volume,operative time,length of surgical incisions,length of hospital stays,and complications of both groups of patients were recorded and compared.The visual analogue scale(VAS)was used to evaluate patients'low back pain and Oswestry disability index(ODI)was used to assess the lumbar function before surgery,at 1 week,1 month,3 months and 6 months after surgery.The patients were also evaluated using the modified Macnab criteria for treatment efficacy,and using the Bridwell criteria for assessing the segmental fusion within 1 year after surgery.Results:The intraoperative blood loss and postoperative drainage volume in the observation group were 88.46±10.98mL and 159.73±18.42mL,lower than those in the control group 112.99±12.01mL and 201.36±23.06mL(P＜0.05);The lengths of surgical incision and hospital stays were 1.54±0.36cm and 6.79±1.22d,which were shorter in the observation group than those in the control group of 5.43±1.01cm and 8.03±1.43d(P＜0.05);And the operative time was longer in the observation group than that in the control group(162.33±19.57min vs 126.87±23.15min,P＜0.05).All the patients were followed up for 15-40 months(19.0±6.3 months).At 1 week and 1 month after surgery,VAS scores in observation group were 2.46±0.51 and 1.21±0.38,and ODI were(17.84±4.15)％and(10.69±1.88)％,which were lower than those in the control group[VAS score:3.68±0.62,2.01±0.41;ODI:(21.33±3.48)％,(12.33±2.17)％,P＜0.05].At 3 months and 6 months after surgery,there was no significant difference in VAS scores between the two groups(P＞0.05).There was neither significant difference in the excellent and good rate of treatment(92.11％vs 85.71％,P=0.487)nor significant difference in fusion grading between the observation group and control group(Z=0.487,P=0.624).No significant difference was noticed in the incidence of postoperative complications between observation group and control group(5.26％vs 9.52％,P=0.678).Conclusions:The curative effect of Endo-PLIF is satisfactory on degenerative lumbar diseases,which can reduce intraoperative blood loss,shorten surgical incision and hospitalization time,improve short-term pain and lumbar function faster,with good safety.

OBJECTIVE: To investigate the treatment and prognosis of the patients with squamous cell carcinoma of thyroid. METHOD: The clinical data of all patients with squamous cell carcinoma of the thyroid in our hospital from Dec. 1994 to Dec. 2008 were analyzed retrospectively. RESULT: The overall 1-year, 3-year survival rates were 36.4% and 9.1% respectively. The median survival time was 8 months. Survival analysis showed the patients receiving surgery and postoperative radiotherapy had a better prognosis. CONCLUSION The prognosis of squamous cell carcinoma of thyroid was poor; the patients with squamous cell carcinoma of thyroid maybe get a better prognosis by receiving surgery and postoperative radiotherapy.
Adult ; Carcinoma, Squamous Cell ; diagnosis ; therapy ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; Retrospective Studies ; Thyroid Neoplasms ; diagnosis ; therapy

Objective:To study the patterns of tocilizumab (TCZ) use, its efficacy and safety in patients with rheumatoid arthritis (RA) in routine clinical practice.Methods:A total of 407 patients with RA were enrolled from 23 centers and treated with TCZ within 8 weeks prior to the enrollment visit, and were followed for 6-month. The patterns of TCZ treatment at 6 months, the effectiveness and safety outcomes were recorded. Statistical analysis was performed using SAS version 9.4.Results:A total of 396 patients were included for analysis, in which 330 (83.3%) patients received TCZ combined with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs), and 16.7%(66/396) received TCZ monotherapy. At baseline, TCZ was initiated in 56.6%(224/396) and 9.6%(38/396) of patients after failure of DMARDs and other biological agents (bDMARDs) respectively. During the 6-month follow-up period, the mean frequency of TCZ administration was (3.7±1.6), the mean TCZ dosage was (7.4±1.2) mg/kg, and the mean interval between doses was (40±13) days. 120(25.8%) patients were on TCZ treatment at the end of the study. Improvements in disease activity, systemic symptoms and patient report outcomes were observed at the end of the study. 22.7%(90/396) patients experienced at least one treatment related adverse event, and 8 patients experienced at least one serious adverse event.Conclusion:This study demonstrates that TCZ treatment is effective in patients with RA when being treated for 6 months with an acceptable safety profile. The duration of TCZ treatment needs to be extended.